Fig. 1
From: Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany
Workflow of the study. The medication plans of a total of 728 patients with multiple sclerosis (MS) were collected between March 2017 and June 2022. More specifically, we recorded the brand name, route of administration, dosage and application frequency of each long-term prescription medication being used. Drug prices were gathered in May 2024 from LAUER-TAXE Online49, a database for healthcare professionals that provides pricing information and reimbursement rates for pharmaceutical products available in Germany. We then determined the patients’ individual annual medication costs in € and analyzed the contributing factors.
